OCT 17, 2020 8:00 AM PDT

Imaging Innovation Set to Ease the Pain of Osteoarthritis

WRITTEN BY: Tara Fernandez

In osteoarthritis, the joint cartilage that cushions bones begins to break down, causing debilitating pain and stiffness. It’s the most common form of degenerative joint disease, affecting almost 240 million people around the world.

Australian researchers have developed a cutting edge imaging technique to visualize the signs of osteoarthritis. Using mass spectrometry imaging, the scientists were able to paint a molecular picture of osteoarthritic cartilage, revealing that damaged tissue had numerous signature patterns of the expression of different sugars. The study was published in the International Journal of Molecular Sciences.

"It is one of the most common degenerative joint diseases, yet there are limited diagnostic tools, few treatment options and no cure," said lead scientist Paul Anderson from the University of South Australia.

For now, diagnostics rely on biomarkers present in bodily fluids — a test that lacks both precision and accuracy. The new imaging platform can map changes on molecular level in different anatomical regions, thus helping to inform optimal clinical strategies to slow the progression of the condition. Mass spectrometry already has a stellar track record in diagnostic settings, demonstrating its efficacy in identifying cancer biomarkers, for example.

“To date, diagnosing osteoarthritis has relied heavily on x-rays or MRI, but these provide limited information and don't detect biomolecular changes that signal cartilage and bone abnormalities,” said Olivia Lee, a graduate student who contributed to the study.

“By contrast, alternative imaging methods such as MSI can identify specific molecules and organic compounds in the tissue section." Osteoarthritis is a heavy burden on healthcare systems and patients due to loss of work productivity, costs of treatments, and the diminished quality of life during osteoarthritis flare ups. These next generation diagnostic technologies are a light at the end of the tunnel for transforming osteoarthritis standards of care.

Sources: International Journal of Molecular Sciences, University of South Australia.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
OCT 02, 2020
Clinical & Molecular DX
Detecting Dystonia in the Blink of an AI
OCT 02, 2020
Detecting Dystonia in the Blink of an AI
A team of scientists have created a diagnostic tool, powered by artificial intelligence (AI), that can pick up on the su ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
OCT 29, 2020
Clinical & Molecular DX
Skin Deep: A Novel Test for Parkinson's
OCT 29, 2020
Skin Deep: A Novel Test for Parkinson's
In Parkinson’s disease (PD), there is chronic degeneration of the central nervous system, particularly in the regi ...
OCT 29, 2020
Cannabis Sciences
Hemp 10 Years from Now
OCT 29, 2020
Hemp 10 Years from Now
The hemp industry has experienced major growth in recent years, largely due to legalization in many US states. Today, th ...
DEC 10, 2020
Clinical & Molecular DX
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
DEC 10, 2020
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
A study by Duke University researchers has revealed that children’s gut microbiomes hold clues as to their possibl ...
Loading Comments...